BioHarvest Sciences Total Liabilities and Share Holders Equity 2020-2024 | BHST
BioHarvest Sciences total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
BioHarvest Sciences Annual Total Liabilities and Share Holders Equity (Millions of US $) |
2023 |
$15 |
2022 |
$9 |
2021 |
$10 |
2020 |
$5 |
2019 |
$2 |
2019 |
$6 |
2018 |
$6 |
BioHarvest Sciences Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
2024-06-30 |
$27 |
2024-03-31 |
$13 |
2023-12-31 |
$15 |
2023-09-30 |
$11 |
2023-06-30 |
$11 |
2023-03-31 |
$8 |
2022-12-31 |
$9 |
2022-09-30 |
$10 |
2022-06-30 |
$8 |
2022-03-31 |
$8 |
2021-12-31 |
$10 |
2021-09-30 |
$12 |
2021-06-30 |
$8 |
2021-03-31 |
$10 |
2020-12-31 |
$5 |
2020-09-30 |
$4 |
2020-06-30 |
$3 |
2020-03-31 |
$0 |
2019-12-31 |
|
2019-09-30 |
$0 |
2019-06-30 |
$0 |
2019-03-31 |
$6 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|